# Tango Therapeutics, Inc.: filings

TNGX · Nasdaq · CIK 1819133 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tngx.md) · [Financials](/companies/tngx/financials.md) · [Filings](/companies/tngx/filings.md) · [Insiders](/companies/tngx/insiders.md)

## Reports and events: 97 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 114, 8-K 50, 144 43, 3 36, SCHEDULE 13G/A 23, 10-Q 18, SC 13G 10, SC 13G/A 10, EFFECT 9, CORRESP 8, SC 13D/A 8, SCHEDULE 13G 8, 424B3 7, 10-K 6, S-8 6, UPLOAD 6, DEF 14A 5, 424B5 4, ARS 4, DEFA14A 4, S-3 4, SCHEDULE 13D/A 4, S-4/A 3, 4/A 2, D 2, FWP 2, POS AM 2, PRE 14A 2, S-1 2, SC 13D 2, SEC STAFF LETTER 2, 424B4 1, 425 1, 8-A12B 1, 8-K/A 1, CERT 1, DEFR14A 1, S-1/A 1, S-1MEF 1, S-3ASR 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 06:36 ET | [8-K](/filings/0001193125-26-429423.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429423 |
| 2026-08-11 | 21:13 ET | [8-K](/filings/0001193125-26-344997.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-344997 |
| 2026-08-11 | 11:20 ET | [8-K](/filings/0001193125-26-343434.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343434 |
| 2026-08-11 | 11:12 ET | [10-Q](/filings/0001193125-26-343424.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343424 |
| 2026-08-07 | 10:41 ET | [8-K/A](/filings/0001193125-26-339070.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-339070 |
| 2026-08-06 | 21:30 ET | [8-K](/filings/0001193125-26-338480.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-338480 |
| 2026-06-23 | 21:19 ET | [8-K](/filings/0001193125-26-279788.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-279788 |
| 2026-06-10 | 21:22 ET | [8-K](/filings/0001193125-26-266078.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-266078 |
| 2026-06-08 | 11:15 ET | [8-K](/filings/0001193125-26-260679.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-260679 |
| 2026-06-04 | 21:19 ET | [8-K](/filings/0001193125-26-257760.md) | 5.07 Shareholder vote results | 0001193125-26-257760 |
| 2026-05-13 | 20:16 ET | [8-K](/filings/0001193125-26-221677.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-221677 |
| 2026-05-13 | 20:15 ET | [10-Q](/filings/0001193125-26-221656.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221656 |
| 2026-05-08 | 13:22 ET | [8-K](/filings/0001193125-26-213491.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-213491 |
| 2026-04-17 | 11:12 ET | [DEF 14A](/filings/0001193125-26-160287.md) | Proxy statement, period 2026-04-16 | 0001193125-26-160287 |
| 2026-04-15 | 13:19 ET | [8-K](/filings/0001193125-26-156127.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-156127 |
| 2026-03-05 | 12:15 ET | [8-K](/filings/0001193125-26-092535.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092535 |
| 2026-03-05 | 12:10 ET | [10-K](/filings/0001193125-26-092518.md) | Annual report, period 2025-12-31 | 0001193125-26-092518 |
| 2026-02-10 | 21:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-044719.md) | Ownership report, active investor, amended | 0001193125-26-044719 |
| 2026-01-08 | 14:10 ET | [8-K](/filings/0001193125-26-007086.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007086 |
| 2026-01-05 | 12:09 ET | [8-K](/filings/0001193125-26-001495.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-001495 |
| 2025-11-21 | 21:15 ET | [SCHEDULE 13D/A](/filings/0001193125-25-291391.md) | Ownership report, active investor, amended | 0001193125-25-291391 |
| 2025-11-21 | 13:36 ET | [8-K](/filings/0001193125-25-290679.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-25-290679 |
| 2025-11-14 | 21:15 ET | [SCHEDULE 13D/A](/filings/0001193125-25-282980.md) | Ownership report, active investor, amended | 0001193125-25-282980 |
| 2025-11-04 | 14:10 ET | [8-K](/filings/0001193125-25-263684.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263684 |
| 2025-11-04 | 14:09 ET | [10-Q](/filings/0001193125-25-263680.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263680 |
| 2025-10-24 | 10:17 ET | [8-K](/filings/0001193125-25-249302.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-249302 |
| 2025-10-23 | 11:04 ET | [8-K](/filings/0001193125-25-247658.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-247658 |
| 2025-08-25 | 20:06 ET | [8-K](/filings/0001193125-25-187680.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-187680 |
| 2025-08-05 | 11:10 ET | [10-Q](/filings/0000950170-25-102392.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102392 |
| 2025-08-05 | 11:06 ET | [8-K](/filings/0000950170-25-102387.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102387 |
| 2025-06-06 | 20:02 ET | [8-K](/filings/0001193125-25-137032.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-137032 |
| 2025-05-12 | 11:10 ET | [10-Q](/filings/0000950170-25-068549.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068549 |
| 2025-05-12 | 11:06 ET | [8-K](/filings/0000950170-25-068546.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068546 |
| 2025-04-21 | 18:29 ET | [DEF 14A](/filings/0000950170-25-056230.md) | Proxy statement, period 2025-04-21 | 0000950170-25-056230 |
| 2025-02-27 | 12:12 ET | [10-K](/filings/0000950170-25-028353.md) | Annual report, period 2024-12-31 | 0000950170-25-028353 |
| 2025-02-27 | 12:06 ET | [8-K](/filings/0000950170-25-028345.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028345 |
| 2025-01-13 | 12:30 ET | [8-K](/filings/0001193125-25-004977.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004977 |
| 2025-01-02 | 12:07 ET | [SCHEDULE 13D/A](/filings/0000895345-25-000001.md) | Ownership report, active investor, amended | 0000895345-25-000001 |
| 2024-11-07 | 02:35 ET | [SC 13D/A](/filings/0000895345-24-000549.md) | Ownership report, active investor, amended | 0000895345-24-000549 |
| 2024-11-06 | 12:43 ET | [10-Q](/filings/0000950170-24-121818.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121818 |
| 2024-11-06 | 12:23 ET | [8-K](/filings/0000950170-24-121810.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-121810 |
| 2024-10-28 | 13:22 ET | [SC 13D/A](/filings/0000895345-24-000491.md) | Ownership report, active investor, amended | 0000895345-24-000491 |
| 2024-10-15 | 01:40 ET | [SC 13D/A](/filings/0000895345-24-000428.md) | Ownership report, active investor, amended | 0000895345-24-000428 |
| 2024-10-15 | 23:25 ET | [SC 13D/A](/filings/0000895345-24-000424.md) | Ownership report, active investor, amended | 0000895345-24-000424 |
| 2024-09-04 | 00:45 ET | [SC 13D/A](/filings/0001193125-24-213369.md) | Ownership report, active investor, amended | 0001193125-24-213369 |
| 2024-08-07 | 11:13 ET | [10-Q](/filings/0000950170-24-092274.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092274 |
| 2024-08-07 | 11:07 ET | [8-K](/filings/0000950170-24-092270.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092270 |
| 2024-06-06 | 20:06 ET | [8-K](/filings/0001193125-24-156048.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-156048 |
| 2024-05-23 | 11:18 ET | [8-K](/filings/0001193125-24-145434.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-145434 |
| 2024-05-08 | 11:21 ET | [10-Q](/filings/0000950170-24-055065.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055065 |

Page 1 of 2. [Older](/companies/tngx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.